Medical Marketing Has Increased in Past 20 Years
Considerable increase seen from 1997 through 2016, especially in direct-to-consumer advertising
Costs Higher for Those With Comorbid Noncommunicable Diseases
Health expenditure greater for person with two diseases simultaneously than for the diseases separately
Childhood Hodgkin Lymphoma Survivors at Risk for Later Cancers
Survivors have 14-fold increased risk for developing a solid subsequent malignant neoplasm
Health Benefits of Nonsugar Sweeteners Uncertain
However, large systematic review could not rule out harms from nonsugar sweeteners
December 2018 Briefing – Diabetes & Endocrinology
Here are what the editors at HealthDay consider to be the most important developments in Diabetes & Endocrinology for December 2018. This roundup includes...
No Increased Fracture Risk With Canagliflozin in Type 2 Diabetes
Rate of the primary outcome was similar for canagliflozin, glucagon-like peptide-1 agonist
Three Novel Loci Associated With Polycystic Ovary Syndrome ID’d
Genetic links with obesity, T2DM, lipids suggest shared genetic architecture for PCOS, metabolic traits
Incidence of End-Stage Kidney Disease Up in Australia
Incidence increased for nonindigenous people with type 2 diabetes; greatest increase for under 50s, over 80s
Pregnancy Complications Up for Women Born at Low Birth Weight
Risk greatest for women born with birth weight <2,500 g who develop overweight/obesity
Sugar-Sweetened Drinks Linked to Chronic Kidney Disease Risk
Odds of CKD up with beverage pattern consisting of higher intake of sweetened soda, fruit drinks, water
